At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Haemonetics reports second-quarter results on November 5, 2026. Haemonetics stock costs EUR 105.50 o

/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Earnings per share hit USD 1.14 versus USD 1.09. Haemonetics stock was last at USD 118.28 on October

Find the latest Haemonetics Corporation (HAE) stock quote, history, news and other vital information to help you with your stock trading and investing.

Haemonetics reports second-quarter results on November 5, 2026. Haemonetics stock costs EUR 107.50 o

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Haemonetics (HAE) just saw its stock jump more than 13% after CSL Plasma committed to deploy the NexSys PCS devices with Persona PLUS technology across all US plasma centers by the end of 2027. That move landed on top of an already strong run. Haemonetics has a 90-day share price return of 56.81% and a year-to-date share price return of 49.37%, while its 1-year total shareholder return of 138.23% points to momentum that has been building, not just a one-day reaction to the CSL update. Scan...

Haemonetics shares surged to a 52-week high after CSL Plasma disclosed plans to deploy NexSys PCS devices with Persona PLUS technology across all of…